4//SEC Filing
Cassella James V 4
Accession 0001209191-22-038901
CIK 0001563880other
Filed
Jun 22, 8:00 PM ET
Accepted
Jun 23, 4:38 PM ET
Size
5.5 KB
Accession
0001209191-22-038901
Insider Transaction Report
Form 4
Cassella James V
Chief Development Officer
Transactions
- Award
Nonstatutory Stock Option (right to buy)
2022-06-23+20,000→ 20,000 totalExercise: $2.27Exp: 2032-06-22→ Common Stock (20,000 underlying)
Footnotes (1)
- [F1]This option was granted on June 23, 2022. This option is scheduled to fully vest on the earlier of (i) the first anniversary of the date of grant and (ii) the date of the next annual meeting of stockholders of the Issuer held following the date of grant, subject to the recipient's continued service as a director, employee or consultant of the Issuer.
Documents
Issuer
Trevi Therapeutics, Inc.
CIK 0001563880
Entity typeother
Related Parties
1- filerCIK 0001353528
Filing Metadata
- Form type
- 4
- Filed
- Jun 22, 8:00 PM ET
- Accepted
- Jun 23, 4:38 PM ET
- Size
- 5.5 KB